Chuan Yan

Chuan Yan

Auto-generated profile, based on publicly available information

Chuan Yan

Department of Radiology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2021 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
YZYuemin Zhu
Yuemin Zhu
SWShuping Weng
Shuping Weng
YLYueming Li
Yueming Li
CYChuan Yan
Chuan Yan
RYRongping Ye
Rongping Ye
LGLanmei Gao
Lanmei Gao

23 September 2020 in Journal of Digital Imaging
Verified
Journal Article
Closed access
PDF file
YLYueming Li
Yueming Li
XXXuru Xu
Xuru Xu
SWShuping Weng
Shuping Weng
CYChuan Yan
Chuan Yan
JCJianwei Chen
Jianwei Chen
RYRongping Ye
Rongping Ye

1 January 2021 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
RYRongping Ye
Rongping Ye
SWShuping Weng
Shuping Weng
YLYueming Li
Yueming Li
CYChuan Yan
Chuan Yan
JCJianwei Chen
Jianwei Chen
LWLiting Wen
Liting Wen
Ye R, et al. Korean J Radiol. 2021 Jan;22(1):106-117. https://doi.org/10.3348/kjr.2020.0121

6 March 2023 in Journal of Computer Assisted Tomography
Verified
Journal Article
Open access
CYChuan Yan
Chuan Yan
ZHZewen Han
Zewen Han
XCXiaojie Chen
Xiaojie Chen
LGLanmei Gao
Lanmei Gao
RYRongping Ye
Rongping Ye
YLYueming Li
Yueming Li
Purpose: This study aimed to explore the predictive performance of diffusion-weighted imaging with apparent diffusion coefficient map in predicting the proliferation rate of hepatocellular carcinoma and to develop a radiomics-based nomogram. Methods: This was a single-center retrospective study. A total of 110 patients were enrolled. The sample included 38 patients with low Ki67 expression (Ki67 ≤10%) and 72 with high Ki67 expression (Ki67 >10%) as demonstrated by surgical pathology. Patients were randomly divided into either a training (n = 77) or validation (n = 33) cohort. Diffusion-weighted imaging with apparent diffusion coefficient maps was used to extract radiomic features and the signal intensity values of tumor (SItumor), normal liver (SIliver), and background noise (SIbackground) from all samples. Subsequently, the clinical model, radiomic model, and fusion model (with clinical data and radiomic signature) were developed and validated. Results: The area under the curve (AUC) of the clinical model for predicting the Ki67 expression including serum α-fetoprotein level (P = 0.010), age (P = 0.015), and signal noise ratio (P = 0.026) was 0.799 and 0.715 in training and validation cohorts, respectively. The AUC of the radiomic model constructed by 9 selected radiomic features was 0.833 and 0.772 in training and validation cohorts, respectively. The AUC of the fusion model containing serum α-fetoprotein level (P = 0.011), age (P = 0.019), and rad score (P < 0.001) was 0.901 and 0.781 in training and validation cohorts, respectively. Conclusions: Diffusion-weighted imaging as a quantitative imaging biomarker can predict Ki67 expression level in hepatocellular carcinoma across various models.

22 June 2024 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
HDHanting Dai
Hanting Dai
CYChuan Yan
Chuan Yan
WHWanrong Huang
Wanrong Huang
YPYifan Pan
Yifan Pan
FPFeng Pan
Feng Pan
YLYueming Li
Yueming Li
Backgrounds: Anti‐vascular endothelial growth factor (VEGF) therapy has been developed and recognized as an effective treatment for hepatocellular carcinoma (HCC). However, there remains a lack of noninvasive methods in precisely evaluating VEGF expression in HCC.Purpose: To establish a visual noninvasive model based on clinical indicators and MRI features to evaluate VEGF expression in HCC.Study Type: Retrospective.Population: One hundred forty HCC patients were randomly divided into a training (N = 98) and a test cohort (N = 42).Field Strength/Sequence: 3.0 T, T2WI, T1WI including pre‐contrast, dynamic, and hepatobiliary phases.Assessment: The fusion model constructed by history of smoking, albumin‐to‐globulin ratio (AGR) and the Radio‐Tree model was visualized by a nomogram.Statistical Tests: Performances of models were assessed by receiver operating characteristic (ROC) curves. Student's t‐test, Mann–Whitney U‐test, chi‐square test, Fisher's exact test, univariable and multivariable logistic regression analysis, DeLong's test, integrated discrimination improvement (IDI), Hosmer–Lemeshow test, and decision curve analysis were performed. P < 0.05 was considered statistically significant.Results: History of smoking and AGR ≤1.5 were clinical independent risk factors of the VEGF expression. In training cohorts, values of area under the curve (AUCs) of Radio‐Tree model, Clinical‐Radiological (C‐R) model, fusion model which combined history of smoking and AGR with Radio‐Tree model were 0.821, 0.748, and 0.871. In test cohort, the fusion model showed highest AUC (0.844) than Radio‐Tree and C‐R models (0.819, 0.616, respectively). DeLong's test indicated that the fusion model significantly differed in performance from the C‐R model in training cohort (P = 0.015) and test cohort (P = 0.007).Data Conclusion: The fusion model combining history of smoking, AGR and Radio‐Tree model established with ML algorithm showed the highest AUC value than others.Evidence Level: 4Technical Efficacy: Stage 2

14 September 2024 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
RYRongping Ye
Rongping Ye
YZYao Zheng
Yao Zheng
FPFeng Pan
Feng Pan
HWHuifang Wang
Huifang Wang
CYChuan Yan
Chuan Yan
YLYueming Li
Yueming Li